Viewing Study NCT00564928


Ignite Creation Date: 2025-12-26 @ 10:37 AM
Ignite Modification Date: 2026-01-13 @ 3:30 PM
Study NCT ID: NCT00564928
Status: COMPLETED
Last Update Posted: 2012-12-11
First Post: 2007-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
Sponsor: Infinity Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module